ASX-Dividend-Report-Banner

Mediwave Earns Global Recognition at GLOMO Awards 2024 for Emergency Response HealthTech

March 18, 2024 11:00 AM AEDT | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp
 Mediwave Earns Global Recognition at GLOMO Awards 2024 for Emergency Response HealthTech
Image source: Kalkine Media

SINGAPORE, March 18, 2024 /PRNewswire/ -- Mediwave, a leading-edge HealthTech company, was recognised as a finalist at the prestigious Global Mobile Awards (GLOMO), part of the Mobile World Congress (MWC) powered by GSMA in Barcelona, Spain. This acknowledgment underscores Mediwave's exceptional contributions to the field, particularly its innovative and integrated use of AI, Internet of Medical Things (IoMT), and Mixed Reality technologies.

End-to-End Emergency Response Suite
End-to-End Emergency Response Suite

Mediwave has transformed Sri Lanka's national-level free pre-hospital emergency care ambulance service, 1990 Suwa Seriya, with its end-to-end Emergency Response Suite. This solution, recently featured as the world's first of its kind, digitises and augments the service delivery with AI, AR, and mixed reality capabilities. This achievement is a significant milestone for Mediwave as it expands its global reach with a suite of life enhancing HealthTech solutions, including Emergency Response, Digital Healthcare Enablement, and AI Smart Health portfolio.

The company also showcased its full range of innovations at 4 Years From Now (4YFN), an integral part of the MWC GSMA, which serves as a catalyst for startups taking centre stage in future-proof tech, providing them with invaluable networking opportunities and exposure.

Mediwave's Chief Executive Officer, Suren Pinto, reflected on attending the event, stating, "It was a proud and humbling moment for our Emergency Response Suite to be showcased alongside leading global brands at the GLOMO Awards. We are grateful for the 1990 Suwa Seriya Foundation for collaborating with us to bring this solution to life and create tremendous impact in Sri Lanka. With our pioneering solutions, we have ventured into Australia, the USA, and selected Asian countries. As an emerging force in the healthcare space, I look forward to the many milestones and growth stories we will build together with industry veterans."

Mediwave is transforming the healthcare ecosystem by introducing life-enhancing technology that can be seamlessly integrated into multiple industries impacted by emergencies and life-threatening scenarios. Their innovative technology allows for swift, proactive, and immersive interventions, enhancing connected patient care with a scalable architecture.

About Mediwave:

Headquartered in Singapore, Mediwave is setting a new pace for impact at the intersection of Artificial Intelligence (AI) and Augmented Reality (AR), catalysing a connected world in the delivery of healthcare. The company is among the select few end-to-end solution providers in the global HealthTech space, driving transformative change and forging a robust healthcare ecosystem globally. Connect with Mediwave here: www.mediwave.io 

Mediwave Global Marketing
[email protected]


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.